Editor’s note: A recording of the conversation is embedded below.
Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT health tech correspondent Erin Brodwin will be joined by Glen Tullman, executive chairman and CEO of Transcarent. Coming off the success of Livongo, Tullman will discuss his new ideas for revamping employer-based health, and of course be taking your questions live.
Create a display name to comment
This name will appear with your comment